Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach
Main Article Content
Abstract
Abstract
Cite this article as: Nisar MK. Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach. Eur J Rheumatol 2019; 6(1): 57-8.